GOSS Gossamer Bio
- 0.696
- +0.031+4.66%
- 0.690
- -0.005-0.78%
Gossamer Bio News
Gossamer Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Raymond Debbane(6.3%),Invus Public Equities, L.P.(5.9%), etc.
Gossamer Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(3.507%),Abigail P. Johnson(3.507%)
Gossamer Bio | 10-Q: Q3 2024 Earnings Report
Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio | 8-K: Current report
Gossamer Bio | 8-K: Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio | 10-Q: Q2 2024 Earnings Report
Gossamer Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(6.3%),Invus Public Equities Advisors, LLC(6.3%), etc.
Gossamer Bio | 8-K: Current report
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Officer Aranda Richard
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Officer Hasnain Faheem
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Officer Giraudo Bryan
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Officer Smith Robert Paul JR
Gossamer Bio | 8-K: Current report
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Director Quisel John D
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Director Milligan Sandra
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Director Cox Russell J.
Gossamer Bio | 4: Statement of changes in beneficial ownership of securities-Director Daniel Thomas O
Gossamer Bio | 8-K: Current report
Gossamer Bio | 10-Q: Q1 2024 Earnings Report
Analysis
Price Target
No Data
No Data